Lantheus Holdings, Inc. (LNTH) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LNTH Revenue Growth
Revenue Breakdown (FY 2025)
LNTH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
LNTH Revenue Analysis (2014–2025)
As of May 8, 2026, Lantheus Holdings, Inc. (LNTH) generated trailing twelve-month (TTM) revenue of $1.55 billion, reflecting modest growth of +1.2% year-over-year. The most recent quarter (Q1 2026) recorded $377.3 million in revenue, down 7.2% sequentially.
Looking at the longer-term picture, LNTH's 5-year compound annual growth rate (CAGR) stands at +35.3%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $1.54 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows LNTH's business is primarily driven by Product (33%), PYLARIFY (22%), and Radiopharmaceutical Oncology (22%).
When compared to Healthcare sector peers including RMD (+10.3% YoY), BWXT (+21.4% YoY), and EXAS (+17.7% YoY), LNTH has underperformed the peer group in terms of revenue growth. Compare LNTH vs RMD →
LNTH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LNTHCurrent | $1.5B | +1.2% | +35.3% | 20.2% | |
 RMD | $5.1B | +10.3% | +11.7% | 32.7% | |
 BWXT | $3.2B | +21.4% | +8.5% | 10.1% | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% | |
 ROIV | $29M | -56.4% | -15.6% | -3453.3% | |
 GE | $45.9B | +21.9% | -9.6% | 19.1% |
LNTH Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.54B | +0.5% | $942.0M | 61.1% | $310.8M | 20.2% |
| 2024 | $1.53B | +18.3% | $988.3M | 64.4% | $457.0M | 29.8% |
| 2023 | $1.30B | +38.6% | $709.5M | 54.7% | $364.6M | 28.1% |
| 2022 | $935.1M | +119.9% | $581.7M | 62.2% | $36.2M | 3.9% |
| 2021 | $425.2M | +25.3% | $187.7M | 44.1% | $-60,825,000 | -14.3% |
| 2020 | $339.4M | -2.3% | $138.8M | 40.9% | $-4,198,000 | -1.2% |
| 2019 | $347.3M | +1.2% | $174.8M | 50.3% | $51.7M | 14.9% |
| 2018 | $343.4M | +3.6% | $174.9M | 50.9% | $64.5M | 18.8% |
| 2017 | $331.4M | +9.8% | $162.1M | 48.9% | $51.9M | 15.6% |
| 2016 | $301.9M | +2.9% | $137.8M | 45.6% | $56.6M | 18.7% |
See LNTH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LNTH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LNTH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLNTH — Frequently Asked Questions
Quick answers to the most common questions about buying LNTH stock.
Is LNTH's revenue growth accelerating or slowing?
LNTH revenue growth slowed to +1.2%, below the 5-year CAGR of +35.3%. TTM revenue is $1.5B. The deceleration marks a shift from historical growth rates.
What is LNTH's long-term revenue growth rate?
Lantheus Holdings, Inc.'s 5-year revenue CAGR of +35.3% reflects the variable expansion pattern. Current YoY growth of +1.2% is near this long-term average.
How is LNTH's revenue distributed by segment?
LNTH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.